[go: up one dir, main page]

GB0219022D0 - Novel thyromimetic compounds - Google Patents

Novel thyromimetic compounds

Info

Publication number
GB0219022D0
GB0219022D0 GBGB0219022.1A GB0219022A GB0219022D0 GB 0219022 D0 GB0219022 D0 GB 0219022D0 GB 0219022 A GB0219022 A GB 0219022A GB 0219022 D0 GB0219022 D0 GB 0219022D0
Authority
GB
United Kingdom
Prior art keywords
thyromimetic compounds
novel
novel thyromimetic
compounds
thyromimetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0219022.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karo Healthcare AB
Original Assignee
Karo Bio AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karo Bio AB filed Critical Karo Bio AB
Priority to GBGB0219022.1A priority Critical patent/GB0219022D0/en
Publication of GB0219022D0 publication Critical patent/GB0219022D0/en
Priority to AU2003251705A priority patent/AU2003251705A1/en
Priority to PCT/EP2003/008974 priority patent/WO2004018421A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0219022.1A 2002-08-15 2002-08-15 Novel thyromimetic compounds Ceased GB0219022D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0219022.1A GB0219022D0 (en) 2002-08-15 2002-08-15 Novel thyromimetic compounds
AU2003251705A AU2003251705A1 (en) 2002-08-15 2003-08-13 Idol derivatives as new thyroid receptor agonist ligands and methods
PCT/EP2003/008974 WO2004018421A1 (en) 2002-08-15 2003-08-13 Idol derivatives as new thyroid receptor agonist ligands and methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0219022.1A GB0219022D0 (en) 2002-08-15 2002-08-15 Novel thyromimetic compounds

Publications (1)

Publication Number Publication Date
GB0219022D0 true GB0219022D0 (en) 2002-09-25

Family

ID=9942387

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0219022.1A Ceased GB0219022D0 (en) 2002-08-15 2002-08-15 Novel thyromimetic compounds

Country Status (3)

Country Link
AU (1) AU2003251705A1 (en)
GB (1) GB0219022D0 (en)
WO (1) WO2004018421A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200504021A (en) 2003-01-24 2005-02-01 Bristol Myers Squibb Co Substituted anilide ligands for the thyroid receptor
BRPI0416639A (en) 2003-11-19 2007-01-16 Metabasis Therapeutics Inc phosphorus-containing thyromimetics
AU2006249350B2 (en) 2003-11-19 2012-02-16 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
JPWO2006088246A1 (en) * 2005-02-18 2008-07-10 武田薬品工業株式会社 GPR34 receptor function regulator
CN101506158A (en) 2006-06-28 2009-08-12 株式会社三和化学研究所 Novel 6-5 series bicyclic heterocyclic derivative and medical application thereof
JP2010500300A (en) 2006-08-08 2010-01-07 サノフィ−アベンティス Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for their preparation, agents containing these compounds, and uses thereof
EP2310372B1 (en) 2008-07-09 2012-05-23 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
DK2470552T3 (en) 2009-08-26 2014-02-17 Sanofi Sa NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE
JP2013538215A (en) 2010-08-31 2013-10-10 エスエヌユー アールアンドディービー ファウンデーション Fetal Reprogramming Application of PPARδ Agonists
WO2012120055A1 (en) 2011-03-08 2012-09-13 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120052A1 (en) 2011-03-08 2012-09-13 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683702B1 (en) 2011-03-08 2014-12-24 Sanofi New substituted phenyl oxathiazine derivatives, method for their manufacture, medicines containing these compounds and their application
EP2683700B1 (en) 2011-03-08 2015-02-18 Sanofi Tetra-substituted oxathiazine derivatives, method for their preparation, their usage as medicament and medicament containing same and its use
WO2012120057A1 (en) 2011-03-08 2012-09-13 Sanofi Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2012120051A1 (en) 2011-03-08 2012-09-13 Sanofi Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
WO2012120058A1 (en) 2011-03-08 2012-09-13 Sanofi Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US11202789B2 (en) 2016-11-21 2021-12-21 Viking Therapeutics, Inc. Method of treating glycogen storage disease
BR112019025659A2 (en) 2017-06-05 2020-08-25 Viking Therapeutics, Inc. compositions for the treatment of fibrosis
EP3768690B1 (en) 2018-03-22 2025-08-27 Viking Therapeutics, Inc. Crystalline forms and methods of producing crystalline forms of a compound
US12102646B2 (en) 2018-12-05 2024-10-01 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001070687A1 (en) * 2000-03-23 2001-09-27 Bayer Aktiengesellschaft Indoles for treating diseases that can be treated using thyroid hormones
EP1347959A1 (en) * 2000-12-27 2003-10-01 Bayer Aktiengesellschaft Indole derivatives as ligands of thyroid receptors
KR20030072396A (en) * 2001-02-08 2003-09-13 카로 바이오 아베 Novel Thyroid Receptor Ligands
DE60208132T2 (en) * 2001-09-26 2006-07-20 Pfizer Products Inc., Groton Indolocarboxylic acid as a thyroid receptor ligand

Also Published As

Publication number Publication date
WO2004018421A1 (en) 2004-03-04
AU2003251705A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
GB0202216D0 (en) Novel compounds
GB0219022D0 (en) Novel thyromimetic compounds
GB0205256D0 (en) Novel compounds
GB0202679D0 (en) Novel compounds
GB0206723D0 (en) Novel compounds
GB0207249D0 (en) Novel compounds
GB0207246D0 (en) Novel compounds
GB0203299D0 (en) Novel compounds
GB0200025D0 (en) Novel compounds
GB0204252D0 (en) Novel compounds
GB0203902D0 (en) Novel compounds
GB0200108D0 (en) Novel compounds
GB0206714D0 (en) Novel compounds
GB0206612D0 (en) Novel compounds
GB0206610D0 (en) Novel compounds
GB0206201D0 (en) Novel compounds
GB0206198D0 (en) Novel compounds
GB0206197D0 (en) Novel compounds
GB0206196D0 (en) Novel compounds
GB0205649D0 (en) Novel compounds
GB0204758D0 (en) Novel compounds
GB0204305D0 (en) Novel compounds
GB0204255D0 (en) Novel compounds
GB0207275D0 (en) Novel compounds
GB0203363D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)